Status:
UNKNOWN
Impact of Continuous Monitoring of PtC02 on Ventilatory Weaning in Neuro-injured Patients
Lead Sponsor:
Centre Hospitalier St Anne
Conditions:
Acute Brain Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators propose to study the value of non invasive continuous transcutaneous PtC02 monitoring for ventilatory withdrawal guidance in neuro-injured patients and to predict the risk of extubat...
Detailed Description
Extubation is part of the daily routine in intensive care and intensive care units. If the procedures for weaning from mechanical ventilation are well supervised by the establishment, in particular, o...
Eligibility Criteria
Inclusion
- major patients (\>18 years)
- admitted in ICU for an acute brain injury defined by a Glasgow Coma Scale \< 8 and the presence of a cerebral lesion identified on a referent Tomodensitometry (TDM) or Magnetic Resonance Imaging (MRI)
- requiring mechanical ventilation during \>48 hours
- eligible for a ventilatory weaning test
Exclusion
- preexisting neurologic evolutive or degenerative affection or preexisting diaphragmatic dysfunction
- preexisting decision of therapeutic limitation
- impossibility to collect an informed consent
- patients aged \<18 years
- pregnancy
- mental illness
- impossibility for the subject to have a good comprehension of the study
- lack of health insurance coverage
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT04819984
Start Date
April 1 2021
End Date
July 1 2022
Last Update
March 29 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.